702 / DOI: 10.3332/ecancer.2016.702ecancer 10
Cellular-mediated inflammatory response, lymphocytes, neutrophils, and monocytes are increasingly being recognised as having an important role in tumorigenesis and carcinogenesis. In this context, studies have suggested that the neutrophil-to-lymphocyte ratio (NLR) can be used as an independent prognostic factor in a variety of cancers. Particularly in breast cancer, several studies have shown that a high NLR is associated with shorter survival. Because the NLR can be easily determined from the full blood count, it could potentially provide a simple and inexpensive test cancer prognosis. This review addresses the possibilities and limitations of using the NLR as a clinical tool for risk stratification helpful for individual treatment of breast cancer patients. The potential underlying phenomena and some perspectives are discussed.
Keywords: breast cancer, inflammation, neutrophil-to-lymphocyte ratio, prognosis
Loading Article Metrics ... Please wait
31 Jan 2017 / DOI: 10.3332/ecancer.2017.717Published:
26 Jan 2017 / DOI: 10.3332/ecancer.2017.716Published:
24 Jan 2017 / DOI: 10.3332/ecancer.2017.715Published:
17 Jan 2017 / DOI: 10.3332/ecancer.2017.713Published: